Grove Bank & Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Buy
2,615
+180
+7% +$9.77K 0.01% 328
2026
Q1
$153K Sell
2,435
-4,444
-65% -$356K 0.02% 288
2025
Q4
$656K Sell
6,879
-7,152
-51% -$701K 0.07% 151
2025
Q3
$1.37M Buy
14,031
+11,093
+378% +$1.15M 0.16% 90
2025
Q2
$316K Buy
2,938
+135
+5% +$13.7K 0.04% 202
2025
Q1
$283K Sell
2,803
-120
-4% -$12.1K 0.04% 201
2024
Q4
$261K Buy
2,923
+122
+4% +$10.7K 0.04% 198
2024
Q3
$235K Buy
2,801
+320
+13% +$25.2K 0.03% 209
2024
Q2
$191K Hold
2,481
0.03% 225
2024
Q1
$170K Hold
2,481
0.03% 243
2023
Q4
$143K Hold
2,481
0.03% 252
2023
Q3
$131K Sell
2,481
-1,007
-29% -$52.8K 0.03% 252
2023
Q2
$189K Sell
3,488
-81
-2% -$4.23K 0.04% 220
2023
Q1
$179K Buy
3,569
+346
+11% +$16.3K 0.04% 219
2022
Q4
$149K Buy
+3,223
New +$140K 0.03% 238
2018
Q1
Sell
-820
Closed -$20K 195
2017
Q4
$20K Hold
820
0.01% 384
2017
Q3
$24K Hold
820
0.01% 375
2017
Q2
$23K Buy
820
+495
+152% +$13.1K 0.01% 359
2017
Q1
$8K Hold
325
0.01% 355
2016
Q4
$7K Buy
+325
New +$7.09K 0.01% 399

Other funds holding BSX

Grove Bank & Trust's BSX Position: Q2 2026 in Review

Grove Bank & Trust increased its Boston Scientific (BSX) stake by 7.4% in Q2 2026, buying an estimated $9.77K and bringing the position to 2,615 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #328.

Grove Bank & Trust first reported a position in BSX in Q4 2016 and has held it in 20 quarters since. The position peaked at $1.37M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Grove Bank & Trust held 2,615 shares of Boston Scientific worth $112K as of Q2 2026.
  • Grove Bank & Trust bought 180 Boston Scientific shares in Q2 2026, an estimated $9.77K.
  • Boston Scientific made up 0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #328 holding.
  • Grove Bank & Trust first reported a position in Boston Scientific in Q4 2016 and has held it in 20 quarters since.
  • Grove Bank & Trust's Boston Scientific position peaked at $1.37M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.